Akoya Biosciences Inc.
2.81
0.21 (8.08%)
At close: Jan 15, 2025, 1:48 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19
Net Income -63.32M -70.64M -42.94M -16.71M -14.75M
Depreciation & Amortization 8.89M 7.15M 4.79M 3.81M 3.06M
Stock-Based Compensation 10.44M 7.43M 4.04M 477.00K 153.00K
Other Working Capital -2.03M 6.63M -1.32M -574.00K 6.05M
Other Non-Cash Items 7.63M 367.00K 2.75M 3.17M -1.01M
Deferred Income Tax -51.00K 35.00K -155.00K 7.00K 156.00K
Change in Working Capital -14.48M 2.16M -4.56M 2.39M -1.38M
Operating Cash Flow -50.90M -53.50M -36.07M -6.84M -13.78M
Capital Expenditures -3.65M -7.36M -5.09M -3.29M -2.87M
Acquisitions n/a 55.00K n/a 145.00K n/a
Purchase of Investments n/a -40.77M n/a -145.00K -10.00M
Sales Maturities Of Investments 7.00M 34.00M n/a 10.17M n/a
Other Investing Acitivies n/a -6.72M n/a -145.00K -23.00K
Investing Cash Flow 3.35M -14.08M -5.09M 6.73M -12.89M
Debt Repayment 10.57M 30.63M -322.00K 9.79M 4.96M
Common Stock Repurchased n/a n/a n/a n/a n/a
Dividend Paid n/a n/a -1.44M n/a n/a
Other Financial Acitivies -1.70M -1.90M 239.00K -4.30M 48.43M
Financial Cash Flow 56.84M 28.73M 137.03M 5.49M 28.56M
Net Cash Flow 9.29M -38.85M 95.87M 5.37M 1.89M
Free Cash Flow -54.55M -60.86M -41.16M -10.14M -16.64M